Study on Vinpocetine's effects on diabetic cardiomyopathy showed it reduced heart damage, improved markers and structure. Vinpocetine may be a promising treatment for diabetic heart disease.
Jamaica flower extracts from Morelia can lower blood glucose levels, improve lipid metabolism, and reduce insulin resistance in diabetic rats. They could be used as functional ingredients for managing diabetes.
Meta-analysis of 30 studies found Nigella sativa reduces blood sugar and HbA1c levels in adults. More research needed on dosage and duration for optimal results.
Artemisinin shows potential for anti-diabetic and antioxidant effects by targeting the PI3K/AKT pathway. It inhibits enzymes related to hyperglycaemia and exhibits antioxidant properties without toxicity in zebrafish models. This suggests a promising therapy for diabetes and oxidative stress.
Study isolated compounds from plant leaves, showing potential for antioxidant, analgesic, hypoglycemic, and anti-diarrheal properties. Further research needed for exact mechanisms, but promising for potential medicinal use.
C. sativus petal extract promotes cell survival, migration, and angiogenesis, upregulating COL1A1 and VEGF. It accelerates wound closure, making it a potential herbal treatment for diabetic wounds.
Phellinus igniarius SY489 extract contains potent α-glucosidase inhibitors, including novel compounds, with potential as anti-diabetic drugs. Study suggests they interact with enzyme via mixed-type mechanism for promising drug development.
Summary: Review of medicinal plants in the family for treating diabetes, particularly type II diabetes. Limited research, potential for new treatments targeting α-glucosidase enzyme. Important for discovering alternative therapies to manage diabetes.